Bafna Pharmaceuticals Limited BAFNAPH

Latest filings

• Results79 11 Nov, 17:06 · BSE
  We herewith enclose the Unaudited Financial Results for the Quarter and Half Year ended September 30, 2026 as approved by the Board of Directors in its Meeting held on November 11, 2026.
• Results79 11 Nov, 16:46 · BSE
  We hereby inform you that the Board of Directors in its Meeting held on November 11, 2026 inter-alia considered and approved the Unaudited Financial Results of the Company along with the ....
• Board meeting40 6 Nov, 15:17 · BSE
  Bafna Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2026 ,inter alia, to consider and approve the Un-Audited Financial ....
• Routine15 12 Oct, 16:57 · BSE
  Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026
• Routine15 26 Sept, 11:50 · BSE
  Intimation for Closure of Trading Window
• Routine15 11 Sept, 18:18 · NSE
  Voting Results of the 31st Annual General Meeting of the Company held on September 11, 2026 along with the Scrutinizer Report.
• Routine15 11 Sept, 15:09 · NSE
  Proceedings of the 31st Annual General Meeting of the Company held on September 11, 2026
• Routine15 21 Aug, 16:46 · BSE
  Bafna Pharmaceuticals Ltd - 532989 - Announcement under Regulation 30 (LODR)-Newspaper Publication
• Routine15 19 Aug, 21:04 · BSE
  Bafna Pharmaceuticals Ltd - 532989 - Notice Of 31St Annual General Meeting Of The Company For The F.Y 2025-2026
• Routine15 19 Aug, 20:59 · BSE
  Bafna Pharmaceuticals Ltd - 532989 - Reg. 34 (1) Annual Report.

Shown 15 minutes after publication. Real time with Pro.